Bluebird bio earnings call

Author: khuh

August undefined, 2024

Web1 day ago · Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78. RSI Value: 29.91 BLUE Price... WebMar 29, 2024 · Media Contacts. Jess Rowlands. Head of Corporate Communications (857) 299-6103. [email protected]. Investor Contacts. Courtney O’Leary. …

Bluebird Bio (BLUE) May Report Negative Earnings: Know the …

WebMay 3, 2024 · Bluebird Bio (BLUE Quick Quote BLUE - Free Report) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. This ... primary health eagle rd

Top 5 Health Care Stocks Which Could Rescue Your …

WebFeb 15, 2024 · This biotechnology company is expected to post quarterly loss of $1.82 per share in its upcoming report, which represents a year-over-year change of +39.5%. Revenues are expected to be $7.97... WebThe average Bluebird Bio salary ranges from approximately $56,000 per year for Operations Associate to $210,828 per year for Pharmacologist. Average Bluebird Bio … WebCurrent Price $1.88 Daily Change (-1.8%) -$0.04 Day's Range $1.85 - $1.90 Previous Close $1.91 Open $1.88 Beta 1.44 Volume 457,793 Average Volume 1,727,986 Sector Health Care Market Cap $733M... primary health ent scott morrill

bluebird bio Earnings Preview - bluebird bio …

bluebird bio : Announces Q2 Earnings Call and Upcoming Investor …

WebMay 12, 2024 · bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Results Earnings Conference Call May 11, 2024 8:00 AM ET Company Participants Ingrid Goldberg – Vice President-Investor Relations, bluebird bio, Inc. WebAug 5, 2024 · bluebird bio, Inc. (NASDAQ: BLUE) today announced that the Company will report financial results for the second quarter ended June 30, 2024 on Monday, August … primary health ent state stWebMedia Contacts. Jess Rowlands. Head of Corporate Communications (857) 299-6103. [email protected]. Investor Contacts. Courtney O’Leary. Investor Relations primary health doctors near me my location

"Web25 rows · Mar 10, 2024 · How much profit does bluebird bio generate each year? bluebird bio (NASDAQ:BLUE) has a recorded ... " - Bluebird bio earnings call

Bluebird bio earnings call

bluebird bio, Inc. (BLUE) CEO Nick Leschly on Q1 2024 Results ...

WebFeb 24, 2024 · This estimate points to a year-over-year change of +90.2%. Revenues for the quarter are expected to be $377.64 million, up 70% from the year-ago quarter.Over the last 30 days, the consensus EPS... WebBLUEBIRD BIO, INC. : Nieuws en informatie aandeel BLUEBIRD BIO, INC. BLE Deutsche Boerse AG

Did you know?

WebBLUEBIRD BIO, INC. : Nieuws en informatie aandeel BLUEBIRD BIO, INC. BLE Deutsche Boerse AG WebMar 30, 2024 · Conference Call Calendar. Dividend Calendar. ... bluebird bio BLUE earned $32.23 million, ... bluebird bio reported Q4 earnings per share at $-0.82/share, which did not meet analyst predictions of ...

WebMar 29, 2024 · bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. ... - Management to host conference call today, March 29, 2024 at. Read more. 1/18/2024. bluebird bio, Inc. Announces Pricing of $120 Million … WebMar 31, 2024 · This represents an increase of 185% compared to the typical daily volume of 1,531 call options. bluebird bio Stock Down 3.7 %. ... a price-to-earnings ratio of -0.51 and a beta of 0.95.

WebFeb 9, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ... WebAug 9, 2024 · [email protected] Investor Contacts Courtney O’Leary Investor Relations (978) 621-7347 [email protected] Event Details bluebird bio Second Quarter 2024 Earnings Conference Call Aug 9, 2024 at 8:00 AM EDT Webcast Presentation Click here for webcast Supporting Materials

WebMar 31, 2024 · The consensus estimate for bluebird bio's current full-year earnings is ($4.29) per share. William Blair also issued estimates for bluebird bio's Q3 2024 earnings at ($0.74) EPS and Q4 2024 earnings at ($0.73) EPS. Several other equities research analysts also recently weighed in on the stock.

WebApr 3, 2024 · Bluebird Bio, Inc. (BLUE) CEO Nick Leschly on Q2 2024 Results - Earnings Call Transcript. SA Transcripts Mon, Aug. 09, 2024. primary health ellwood city paWebAug 5, 2024 · bluebird bio is a trademark of bluebird bio, Inc. Contacts Investors & Media Investors: Elizabeth Pingpank, 617-914-8736 [email protected] Media: Jenn Snyder, 617-448-0281... playera celesteWebFeb 24, 2024 · For Bluebird, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has... playera cdgWebNov 2, 2024 · bluebird bio, Inc. (NASDAQ:NASDAQ:BLUE) Q3 2024 Results Earnings Conference Call November 02, 2024 08:00 AM ET Executives Elizabeth Pingpank - Associate Director, Corporate Communications... playera celticsWebMar 29, 2024 · Bluebird (BLUE) delivered earnings and revenue surprises of -26.67% and 99.94%, respectively, for the quarter ended December 2024. Do the numbers hold clues … playera chapsWebApr 10, 2024 · bluebird bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Operational Progress finance.yahoo.com - March 29 at 9:02 AM: Research Analysts Set Expectations for bluebird bio, Inc.'s FY2024 Earnings (NASDAQ:BLUE) americanbankingnews.com - March 29 at 1:24 AM: bluebird bio Earnings Preview … playera champion mujerWebApr 5, 2024 · Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect bluebird bio’s business, particularly … player account management